BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32485311)

  • 1. Repurposing of artemisinin-type drugs for the treatment of acute leukemia.
    Lu X; Efferth T
    Semin Cancer Biol; 2021 Jan; 68():291-312. PubMed ID: 32485311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment.
    Kumar MS; Yadav TT; Khair RR; Peters GJ; Yergeri MC
    Curr Pharm Des; 2019; 25(31):3323-3338. PubMed ID: 31475891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the research on the targets of anti-malaria actions of artemisinin.
    Yang J; He Y; Li Y; Zhang X; Wong YK; Shen S; Zhong T; Zhang J; Liu Q; Wang J
    Pharmacol Ther; 2020 Dec; 216():107697. PubMed ID: 33035577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing.
    Augustin Y; Staines HM; Krishna S
    Pharmacol Ther; 2020 Dec; 216():107706. PubMed ID: 33075360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin-type drugs for the treatment of hematological malignancies.
    Mancuso RI; Foglio MA; Olalla Saad ST
    Cancer Chemother Pharmacol; 2021 Jan; 87(1):1-22. PubMed ID: 33141328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of artemisinin compounds for cancer treatment.
    Lai HC; Singh NP; Sasaki T
    Invest New Drugs; 2013 Feb; 31(1):230-46. PubMed ID: 22935909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutical Utilization and Repurposing of Artemisinin and Its Derivatives: A Narrative Review.
    Guan L; Wang H; Xu X; Fan H
    Adv Biol (Weinh); 2023 Aug; 7(8):e2300086. PubMed ID: 37178448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment.
    Li D; Zhang J; Zhao X
    Cancer Invest; 2021 Sep; 39(8):675-684. PubMed ID: 34241563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents.
    Fröhlich T; Çapcı Karagöz A; Reiter C; Tsogoeva SB
    J Med Chem; 2016 Aug; 59(16):7360-88. PubMed ID: 27010926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global research on artemisinin and its derivatives: Perspectives from patents.
    Liu K; Zuo H; Li G; Yu H; Hu Y
    Pharmacol Res; 2020 Sep; 159():105048. PubMed ID: 32590098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing quinacrine for treatment-refractory cancer.
    Oien DB; Pathoulas CL; Ray U; Thirusangu P; Kalogera E; Shridhar V
    Semin Cancer Biol; 2021 Jan; 68():21-30. PubMed ID: 31562955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy.
    Efferth T
    Semin Cancer Biol; 2017 Oct; 46():65-83. PubMed ID: 28254675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin and its derivatives: a potential treatment for leukemia.
    Lam NS; Long X; Wong JW; Griffin RC; Doery JCG
    Anticancer Drugs; 2019 Jan; 30(1):1-18. PubMed ID: 30540593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.
    Yao Y; Guo Q; Cao Y; Qiu Y; Tan R; Yu Z; Zhou Y; Lu N
    J Exp Clin Cancer Res; 2018 Nov; 37(1):282. PubMed ID: 30477536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent.
    Vandewynckel YP; Laukens D; Geerts A; Vanhove C; Descamps B; Colle I; Devisscher L; Bogaerts E; Paridaens A; Verhelst X; Van Steenkiste C; Libbrecht L; Lambrecht BN; Janssens S; Van Vlierberghe H
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):861-70. PubMed ID: 24987823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities.
    Reiter C; Fröhlich T; Gruber L; Hutterer C; Marschall M; Voigtländer C; Friedrich O; Kappes B; Efferth T; Tsogoeva SB
    Bioorg Med Chem; 2015 Sep; 23(17):5452-8. PubMed ID: 26260339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
    Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W
    ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.
    Li Y; Zhou X; Liu J; Yuan X; He Q
    Anticancer Agents Med Chem; 2020; 20(5):520-535. PubMed ID: 31958040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.